Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02613728 · ClinicalTrials.gov registry record · NA

Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

A NA study of Colorectal Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT02613728: Completed NA study of Colorectal Cancer, sponsored by M.D. Anderson Cancer Center.

NCT02613728 is a NA study of Colorectal Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 32 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02613728, a NA study of Colorectal Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is to learn if RecoverMI care can help to shorten the time that patients are in the hospital after surgery and if it can help them recover sooner. RecoverMI includes the following parts: * Preoperative Education * Early oral intake * Early mobilization * Telemedicine

Conditions Studied

Interventions

  • OTHER Telemedicine
  • BEHAVIORAL Accelerated Recovery Plan
  • BEHAVIORAL Early Discharge
  • BEHAVIORAL Standard Enhanced Care

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2016-05-13
Est. Completion 2022-03-08
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT02613728

The ClinicalTrials.gov registry entry for NCT02613728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 4 interventions - of which Telemedicine is the first listed.

NCT02613728 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02613728 about?

NCT02613728 is a clinical study titled "Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)". The goal of this clinical research study is to learn if RecoverMI care can help to shorten the time that patients are in the hospital after surgery and if it can help them recover sooner. RecoverMI includes the following parts: * Preoperative Education * Early oral intake * Early mobilization * Te...

What is the current status of trial NCT02613728?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-05-13. Estimated completion is 2022-03-08.

What conditions does trial NCT02613728 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT02613728?

The interventions under investigation include: Telemedicine (OTHER), Accelerated Recovery Plan (BEHAVIORAL), Early Discharge (BEHAVIORAL), Standard Enhanced Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT02613728?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02613728 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.